In 2012, the Authority was asked to provide an opinion on the scientific substantiation of a health claim submitted pursuant to Article 14 of Regulation (EC) No 1924/2006 related to the combination of ingredients, among which monacolin K from red yeast rice. On 12 July 2013 [EFSA Journal 2013;11(7):3327.], the Authority issued a scientific opinion establishing a cause and effect relationship between the consumption of a product containing 2 mg of monacolin K from red yeast rice in combination with other ingredients, and the reduction of blood LDL-cholesterol concentrations.
Recital 3, Regulation (EU) 2022/860
In forcesince 1 Jun 2022